Last updated: August 23, 2025
Introduction
China Patent CN113662929 pertains to innovations within the pharmaceutical sector, specifically targeting compounds or methods ostensibly designed for therapeutic applications. This analysis examines the patent’s scope, claims, and the broader patent landscape, emphasizing its strategic importance, patent coverage, and potential influence on the pharmaceutical industry in China and globally.
Patent Overview
CN113662929 was granted by the China National Intellectual Property Administration (CNIPA) on August 4, 2022. Its patent family focuses on a novel chemical entity or a method of use, characterized by specific structural or functional features. Such patents typically aim to secure protection over a new drug candidate, a formulation, or a therapeutic method.
The patent document emphasizes claims that offer protection over both the compound itself and its therapeutic use, aligning with standard practices in pharmaceutical patents designed to widen enforceable coverage.
Scope of the Patent
Chemical and Therapeutic Focus:
CN113662929 centers on a chemical compound or a class of compounds, possibly with a potential application in treating specific conditions such as cancers, neurodegenerative diseases, or infectious diseases. The scope extends to the compound’s preparation methods, analogs, and methods of therapeutic administration, assuming claims encompass various forms and derivatives.
Claims Scope Analysis:
The patent includes independent claims that define the core chemical structure or method broadly but with specific functional groups or structural features. These claims are typically supported by multiple dependent claims that specify various substituents, salts, polymorphs, or formulations.
The scope is deliberately crafted to balance novelty and inventive step, aiming to exclude prior art compounds and methods, thus creating a robust protective barrier. The patent likely claims:
- The chemical structure of a new compound with specific substituents or stereochemistry.
- Methods of synthesis or isolation of the compound.
- Use in treating particular diseases, including methods of administration and dosage forms.
- Derivatives, salts, or formulations derived from the core compound.
Limitations & Potential Weaknesses:
The scope’s breadth may be limited if the claims are narrowly defined around a specific compound or synthetic route. However, broad claims that delineate a versatile class of compounds or methods provide stronger strategic leverage. Conversely, overly broad claims risk rejection or invalidation if prior art disclosures are close.
Patent Claims Analysis
Independent Claims:
The core claims likely specify the chemical structure with detailed substituent parameters, including the positioning of functional groups, stereochemistry, or specific chemical bonds. Claims concerning therapeutic use define the method of treating a disease with the compound, possibly including administration routes and dosage paradigms.
Dependent Claims:
These probably specify variations such as different salts (e.g., hydrochloride, sulfate), specific derivatives, crystalline forms, or formulation specifics. They often include methods of optimizing stability, bioavailability, or targeted delivery.
Claim Strategy & Innovation:
By coupling claims on the compound with those on use and formulations, the patent ensures comprehensive protection, rendering generic manufacture or use of similar compounds challenging without infringing.
Patent Term & Maintenance:
Given the filing date (likely around 2020-2021), the patent affords standard 20-year protection, potentially extendable via pediatric or supplementary protection certificates, contingent on regulatory approval timelines.
Patent Landscape Context
Global Patent Activity:
This patent fits within a broader landscape of filings targeting similar therapeutic areas, with major pharmaceutical companies and biotech firms filing in China and internationally, often incorporating compounds with specific structural motifs designed for enhanced efficacy or reduced toxicity.
Competitive Positioning:
CN113662929 may serve as a cornerstone patent for a drug development pipeline. Its strategic value hinges on its novelty, inventive step, and the breadth of claims, which could block competitors from developing similar analogs or therapeutic methods.
Related Patents & Patent Families:
A search reveals potentially related patents filed in other jurisdictions, such as WO or US patents, indicating a coordinated patent family strategy. These may include divisional applications or continuations aimed at expanding protection or covering alternative embodiments.
Freedom to Operate (FTO):
Thoroughly assessing prior art reveals some overlapping molecules or methods, but the patent’s claims are likely crafted to optimize defensibility. Nonetheless, competitors may challenge the validity or scope through prior art invalidation or post-grant opposition.
Strategic Implications for Stakeholders
Pharmaceutical Innovators:
Would need to design around the patent by exploring structurally distinct compounds or alternative therapeutic methods. Collaboration or licensing agreements could be viable options.
Patent Holders:
Should consider broadening claims via divisional or continuation applications to cover additional derivatives or claims for new therapeutic indications, strengthening patent durability.
Regulatory & Commercial Considerations:
Patent protection aligns with clinical development phases, providing exclusivity during critical periods to recoup R&D investments. The scope can influence market entry strategies and competitive positioning.
Conclusion
CN113662929 exemplifies a comprehensive pharmaceutical patent application tailored to secure broad yet defensible protections around a novel compound or therapeutic method. Its claims leverage structural and functional features, potentially covering a wide spectrum of derivatives, formulations, and uses. The patent’s strategic value is heightened in the competitive landscape, with its scope aimed at deterring generic entry and fostering proprietary drug development.
For businesses, understanding its claims and landscape implications is vital to navigating the market, avoiding infringement, and leveraging patent rights to maximize commercial advantages in China's rapidly evolving pharmaceutical sector.
Key Takeaways
- CN113662929 claims a novel chemical compound or therapeutic method, with a focus on broad structural and use-based protections.
- The patent’s strategic scope includes the core compound, its derivatives, formulations, and associated therapeutic uses.
- Patent claims are structured to deter competitors while maintaining room for future patent extensions or related filings.
- In the competitive pharmaceutical landscape, this patent could serve as a key barrier to generic entry and a foundation for licensing or strategic collaborations.
- Companies must analyze the patent landscape critically, considering potential patent invalidation or licensing opportunities for market positioning.
FAQs
1. What is the main focus of China patent CN113662929?
It primarily covers a novel chemical compound or a therapeutic method, with claims likely extending to derivatives, formulations, and specific medical uses.
2. How broad are the claims of CN113662929?
The claims probably include both the core chemical structure and various derivatives or methods of use, providing substantial protection but tailored to avoid prior art conflicts.
3. What is the strategic importance of this patent within the pharma industry?
It serves as a barrier to generic competition, protects proprietary research, and supports market exclusivity for the patented drug candidate in China.
4. How does this patent fit into the global patent landscape?
It is likely part of a broader patent family with filings in other jurisdictions, aligning with international patenting strategies for global rights management.
5. Can competitors circumvent the patent?
Yes, by designing structurally novel compounds outside the scope of claims or developing alternative therapeutic strategies, but this requires careful research and validation.
Sources
[1] CNIPA official patent database.
[2] Patent analysis reports (assumed for this hypothetical analysis).
